On April 27, 2021 Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, reported that the Company will provide a corporate and financial update for the first quarter 2021, on Thursday, May 6, 2021, before the market opens (Press release, Athenex, APR 27, 2021, View Source [SID1234578556]). Athenex’s management team will host a conference call and live audio webcast at 8:00 am Eastern Time.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
To participate in the call, dial either the domestic or international number fifteen minutes before the conference call begins:
Domestic: (888) 771-4371
International: (847) 585-4405
Passcode: 50156178
The live conference call and replay can also be accessed via audio webcast at the Investor Relations section of the Company’s website, located at View Source